Related Experiment Video
Updated: Jun 11, 2025
09:02
A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
4.4K
Urinary Complement C3 and Vitamin D-Binding Protein Predict Adverse Outcomes in Patients with Acute Kidney Injury
Joseph Hunter Holthoff1,2, Joseph L Alge3, John M Arthur3,4
1Department of Nephrology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA, jhholthoff@uams.edu.
Nephron
|September 30, 2024
Summary
Researchers identified two key urine biomarkers, complement C3 and vitamin D-binding protein, that predict adverse outcomes in patients with acute kidney injury (AKI) after cardiac surgery.
Area of Science:
- Biomarker discovery
- Nephrology
- Translational research
Background:
- Acute kidney injury (AKI) is linked to severe complications, including mortality and the need for dialysis.
- Identifying reliable prognostic biomarkers for AKI is crucial for improving patient outcomes.
- Existing biomarkers often lack specificity across different AKI types and species.
Purpose of the Study:
- To discover and validate prognostic biomarkers for acute kidney injury (AKI).
- To identify biomarkers applicable across diverse AKI phenotypes and species.
- To assess the predictive value of urine biomarkers for adverse outcomes in post-cardiac surgery AKI patients.
Main Methods:
- Urine samples from humans, rats, and mice with AKI were analyzed using liquid chromatography/tandem mass spectrometry.
- Five potential biomarkers were identified, with complement C3 and vitamin D-binding protein validated in a cohort of 157 cardiac surgery patients.
- The association between biomarker concentrations and a composite endpoint (stage 3 AKI or 30-day mortality) was examined.
Main Results:
- Urine complement C3 and vitamin D-binding protein concentrations were significantly higher in patients who experienced adverse outcomes.
- Median urine complement C3, adjusted for creatinine, demonstrated the strongest predictive value.
- These findings suggest a link between these biomarkers and AKI severity and prognosis.
Conclusions:
- Cross-species biomarker discovery is a viable strategy for identifying novel AKI prognostic markers.
- Urine complement C3 and vitamin D-binding protein show promise as early predictors of adverse events in AKI patients post-cardiac surgery.
- These biomarkers could aid in risk stratification and clinical decision-making for AKI management.
Related Concept Videos
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
8
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
8
01:20Acute Kidney Injury V: Interprofessional Care
2
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
2
01:29Acute Kidney Injury III: Clinical Manifestations
2
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
2
01:28Chronic Kidney Disease III: Interprofessional Care
2
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
2
01:24Serum Studies: Renal Function Tests
1
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
1
01:22Acute Kidney Injury I: Introduction
2
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
2